Table 2.
Stage | Function | Key References | |
---|---|---|---|
Inflammation | Adaptive immunity | Promotes lymphocyte migration | Clark et al. 1997 |
Stimulates Th2 cell activation | Nakahara et al. 2006 | ||
Inhibits T cell activation | Kuznetsova and Roberts 2004 | ||
Innate immunity | Inhibits myeloid cell migration | Loike et al. 2001; Talts et al. 1999; Midwood et al. 2009 | |
Stimulates TLR4 mediated cytokine production | |||
Re-epithelialization | Keratinocyte adhesion and migration | Matsuda et al. 1999; Katz et al. 2006; Ishii et al. 2008 | |
Epithelial cytodifferentiation | |||
Tissue rebuilding | Cell migration | ECM-cell interactions | Chiquet-Ehrismann and Chiquet 2003; Tran 2005 |
GFR activation | |||
Cell proliferation | GRF activation | Swindle et al. 2001 | |
ECM synthesis | Cell response to growth factors | El-Karef et al. 2007 | |
Synthesis of GF | Nakao et al. 1998 | ||
ECM assembly | Cross linking of ECM | Lundell et al. 2004 | |
Angiogenesis | EC adhesion and migration | Chung et al. 1996 | |
Cell response to growth factors | Murphy-Ullrich et al. 1991 | ||
Release of EPCs from bone marrow | Ballard et al. 2006 | ||
Serum levels of VEGFA in tumor mice | Tanaka et al. 2004 | ||
Tissue remodelling | Wound contraction | Myofibroblast differentiation, migration, contraction | Tamaoki et al. 2005 |
Cell clearance | Stimulates apoptosis | Nakao et al. 1998; Wallner et al. 2004 | |
Metastasis | Cancer cells: reduced adhesion, enhanced proliferation | Inhibition of syndecan-4 | Huang et al. 2001; |
Activation of Wnt signaling | Ruiz et al. 2004 | ||
Induction of EDNRA | Lange et al. 2007 | ||
Cancer cells: enhanced migration and invasion | Enhanced migration in response to promigratory factors | Lange et al. 2008 | |
Induction of MMPs | Tremble et al. 1994; Kalembeyi et al. 2003; Imai et al. 1994; Siri et al. 1995; Watanabe et al. 2000 | ||
Cleavage by MMPs | |||
Cancer cells: increased dissemination and homing | Downregulated expression blocks lung metastasis | Tavazoie et al. 2008; Calvo et al. 2008 | |
Present in matrix channels of metastatic melanomas | Kaariainen et al. 2006 | ||
Present in matrix conduits of the thymus | Drumea-Mirancea et al. 2006 | ||
Carcinoma associated fibroblasts | Secrete tenascin-C and HGF; necessary for invasion of colorectal carcinomas | De Wever et al. 2004 | |
Lumen formation and secretion of tenascin-C into tubes | Gaggioli et al. 2007 |
Tenascin-C can influence a wide variety of physiological processes during tissue repair and cancer. Tenascin-C exhibits context-specific regulation of innate and adaptive immune cell function during the early inflammatory phase, and stimulates the subsequent re-epithelialization, tissue rebuilding, and tissue remodeling by promoting cell migration and proliferation, ECM synthesis and assembly, angiogenesis, wound contraction and cell death during tissue repair. During tumor angiogenesis, invasion and metastasis tenascin-C induces pro-migratory and pro-proliferative signaling, activates MMPs and is expressed in matrix channels that are associated with metastastic cancer. ECM, extracellular matrix, EDNRA, endothelin receptor type A, EPC, endothelial progenitor, GFR, growth factor receptor, Th2, T helper cells, TLR, toll like receptor